RE:Accelerated Approval - what are the chances? Eoganacht... Excellent post. Thanks for sharing.
This is what I would have expected from an analyst like Ubbin covering TLT.
You deciphered our data in order to make a comparison between 2 subset groups (undertreated group versus optimized group).
This then allows us to compare the best subset group DR % against other Accelerated Approval winners like KEYTRUDA in our own indication and even from different other type of indications in order to put things into perspectives, better assess our chances of getting Accelerated Approval in the context of the spirit of the Accelerated Approval program.
That's the type of exercice the FDA will do.
Our FUD-in-chief FGPSTOCK looks bad. Innocent and lazy in fact.
Again, great post. And thanks for sharing to others.